Kanya Rajangam

Business address
C/O Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco, CA, 94080
Top holdings (ownership)
SNTI and NKTX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Kanya Rajangam has filed 16 SEC EDGAR filings since 09 Jul 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 11 Mar 2025 10 Mar 2025 001-40440
4 Open Document Open Filing FORM 4 10 Mar 2025 06 Mar 2025 001-40440
4 Open Document Open Filing FORM 4 06 Feb 2025 04 Feb 2025 001-40440
4 Open Document Open Filing FORM 4 10 Dec 2024 09 Dec 2024 001-40440
4 Open Document Open Filing 02 Jul 2024 03 Jun 2024 001-41747
4 Open Document Open Filing FORM 4 02 Feb 2024 01 Feb 2024 001-40440
4 Open Document Open Filing FORM 4 SUBMISSION 17 Oct 2023 16 Oct 2023 001-41747
3 Open Document Open Filing FORM 3 SUBMISSION 20 Jul 2023 20 Jul 2023 001-41747
4 Open Document Open Filing FORM 4 02 Feb 2023 01 Feb 2023 001-40440
4 Open Document Open Filing FORM 4 SUBMISSION 20 Jul 2022 18 Jul 2022 001-40440
3 Open Document Open Filing FORM 3 SUBMISSION 15 Jul 2022 05 Jul 2022 001-40440
4 Open Document Open Filing FORM 4 SUBMISSION 19 Jan 2022 14 Jan 2022 001-39370
4 Open Document Open Filing FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021 001-39370
4 Open Document Open Filing FORM 4 SUBMISSION 12 Jan 2021 08 Jan 2021 001-39370
4 Open Document Open Filing FORM 4 SUBMISSION 13 Jul 2020 09 Jul 2020 001-39370
3 Open Document Open Filing FORM 3 SUBMISSION 09 Jul 2020 09 Jul 2020 001-39370